Study Identifies New Role of BioAegis' 'Inflammation Regulator' Gelsolin Relevant for a Range of Inflammatory Diseases
Study Identifies New Role of BioAegis’ ‘Inflammation Regulator’ Gelsolin Relevant for a Range of Inflammatory Diseases April 08, 2021 18:58 ET | Source: BioAegis Therapeutics BioAegis Therapeutics Morristown, New Jersey, UNITED STATES Gelsolin mitigates vascular damage by preventing release of IL-1β microparticles after trauma of high pressure and decompression. Gelsolin is non-immunosuppressive unlike current treatments to quell inflammatory cytokines. MORRISTOWN, N.J., April 08, 2021 (GLOBE NEWSWIRE) -- BioAegis Therapeutics Inc., a c...
Source: globenewswire.com